Advertisement

Testing at Discharge

  • Adam Zivin
  • Gust H. Bardy
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 244)

Abstract

Given the comparatively low morbidity and mortality associated with transvenous ICD implantation and the growing number of patients undergoing the procedure, one has to question the value of practices such as pre-discharge testing and routine follow-up chest X-ray that were established in the era of epicardial systems. These issues and the question of outpatient implantation are discussed in this chapter.

Keywords

Cellular Phone Implantable Cardioverter Defibrillator Therapy Implantable Defibrillator Lethal Arrhythmia Acute Rise 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995;92:59–65Google Scholar
  2. 2.
    Bardy GH, Yee R, Yung W.. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. J Am Coll Cardiol 1996;28:400–410PubMedCrossRefGoogle Scholar
  3. 3.
    Bardy GH Johnson G, Poole JE, Dolack GL, Kudenchuk PG, Kelso D, Mitchell R, Mehra R, Hofer B. A simplified single lead unipolar transvenous cardioverter-defibrillator system. Circulation 1993;88:543PubMedCrossRefGoogle Scholar
  4. 4.
    Daoud EG, Man KC, Morady F, Strickberger SA. Rise in chronic defibrillation energy requirements necessitating implantable defibrillator lead system revision. PACE 1997;20:714–719PubMedCrossRefGoogle Scholar
  5. 5.
    Olsovsky MR, Pelini MA, Shorofsky SR, Gold MR. Temporal stability of defibrillation thresholds with an active pectoral lead system. J Cardiovasc Electrophysiol 1998;9:240244Google Scholar
  6. 6.
    Lurie KG, Iskos D, Fetter J, Peterson CA, Collins JM, Shultz JJ, Fahy GJ, Sakaguchi S, Benditt DG. Prehospital discharge defibrillation testing in ICD recipients: a prospective study based on cost analysis. PACE 1999;22:192–196PubMedCrossRefGoogle Scholar
  7. 7.
    Grimm W, Menz V, Hoffmann J, Timmann U, Funck R, Moosdorf R, Maisch B. Complications of third-generation implantable cardioverter defibrillator therapy. PACE 1999;22:206–211PubMedCrossRefGoogle Scholar
  8. 8.
    Saxon LA, Wiener I, DeLurgio DB, Natterson PD, Laks H, Drinkwater DC, Stevenson WG. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J 1995;130:501–506PubMedCrossRefGoogle Scholar
  9. 9.
    Belott PH. Outpatient pacemaker procedures. Int J Cardiol 1987;17:169–176PubMedCrossRefGoogle Scholar
  10. 10.
    Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. PACE 1998;21:1730–1734PubMedCrossRefGoogle Scholar
  11. 11.
    Bardy GH. The Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). In: Woosley RL, Singh SN, editors. Arrhythmia Treatment and Therapy: Evaluation of Clinical Trial Evidence: Marcel Dekker, Inc.; 2000Google Scholar
  12. 12.
    Heller S, Ormont M, Lidagoster L, Sciacca R, Steinberg J. Psychosocial outcome after ICD implantation: A current perspective. PACE 1998;21:1207–1215PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Adam Zivin
    • 1
  • Gust H. Bardy
    • 1
  1. 1.University of Washington and the Seattle Institute for Cardiac Research SeattleWashingtonUSA

Personalised recommendations